Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center

被引：30
|
作者：
Borogovac, Azra [1 ]
Keruakous, Amany [1 ,2 ]
Bycko, Michelle [1 ]
Holter Chakrabarty, Jennifer [1 ]
Ibrahimi, Sami [1 ]
Khawandanah, Mohamad [1 ]
Selby, George B. [1 ]
Yuen, Carrie [1 ]
Schmidt, Sarah [1 ]
Autry, Marcus T. [1 ]
Al-Juhaishi, Taha [1 ]
Wieduwilt, Matthew J. [1 ]
Asch, Adam S. [1 ]
机构：
[1] Univ Oklahoma, Hematol Oncol Sect, Dept Med, Hlth Sci Ctr, Oklahoma City, OK 73019 USA
[2] Univ Augusta, Hematol Oncol Sect, Dept Med, Augusta, GA USA
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / 06期
关键词：
D O I：
10.1038/s41409-022-01664-z
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
下载
收藏
页码：1025 / 1027
页数：3
相关论文
共 50 条
  • [1] Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center
    Azra Borogovac
    Amany Keruakous
    Michelle Bycko
    Jennifer Holter Chakrabarty
    Sami Ibrahimi
    Mohamad Khawandanah
    George B. Selby
    Carrie Yuen
    Sarah Schmidt
    Marcus T. Autry
    Taha Al-Juhaishi
    Matthew J. Wieduwilt
    Adam S. Asch
    Bone Marrow Transplantation, 2022, 57 : 1025 - 1027
  • [2] Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Pagel, John M.
    West, Howard
    JAMA ONCOLOGY, 2017, 3 (11) : 1595 - 1595
  • [3] Cardiovascular Toxicities After Chimeric Antigen Receptor T-cell (CAR-T) Therapy: A Single Center Experience
    Dalal, Prarthana
    Patel, Nikita
    Cascino, Gregory
    Sinha, Arjun
    Sunderraj, Ashwin
    Feinstein, Matthew J.
    Akhter, Nausheen
    CIRCULATION, 2021, 144
  • [4] Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center
    Alexander D. Heini
    Ulrike Bacher
    Marie-Noëlle Kronig
    Gertrud Wiedemann
    Urban Novak
    Sacha Zeerleder
    Behrouz Mansouri Taleghani
    Michael Daskalakis
    Thomas Pabst
    Bone Marrow Transplantation, 2022, 57 : 1010 - 1012
  • [5] Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center
    Heini, Alexander D.
    Bacher, Ulrike
    Kronig, Marie-Noelle
    Wiedemann, Gertrud
    Novak, Urban
    Zeerleder, Sacha
    Mansouri Taleghani, Behrouz
    Daskalakis, Michael
    Pabst, Thomas
    BONE MARROW TRANSPLANTATION, 2022, 57 (06) : 1010 - 1012
  • [6] Costs, effectiveness, and safety associated with Chimeric Antigen Receptor (CAR) T-cell therapy: Results from a comprehensive cancer center
    Chacim, Sergio
    Monjardino, Teresa
    Cunha, Jose Luis
    Medeiros, Pedro
    Redondo, Patricia
    Bento, Maria Jose
    Mariz, Jose Mario
    PLOS ONE, 2022, 17 (12):
  • [7] Psychosocial care for children receiving chimeric antigen receptor (CAR) T-cell therapy
    Steineck, Angela
    Wiener, Lori
    Mack, Jennifer W.
    Shah, Nirali N.
    Summers, Corinne
    Rosenberg, Abby R.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (05)
  • [8] Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
    Kiesgen, Stefan
    Chicaybam, Leonardo
    Chintala, Navin K.
    Adusumilli, Prasad S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 16 - 26
  • [9] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
    Choi, Taewoong
    Kang, Yubin
    PHARMACOLOGY & THERAPEUTICS, 2022, 232
  • [10] Successful Development of an Outpatient Chimeric Antigen Receptor (CAR) T Cell Therapy Program
    Borogovac, Azra
    Keruakous, Amany R.
    Bycko, Michelle
    Chakrabarty, Jennifer Holter
    Ibrahimi, Sami
    Khawandanah, Mohamad O.
    Selby, George B.
    Yuen, Carrie
    Schmidt, Sarah A.
    Al-Juhaishi, Taha
    Wieduwilt, Matthew
    Asch, Adam S.
    BLOOD, 2021, 138
12345